PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $230,617 | +5.7% | 5,651 | 0.0% | 0.13% | -23.4% |
| Q4 2022 | $218,185 | -99.9% | 5,651 | 0.0% | 0.18% | -32.2% |
| Q3 2022 | $300,577,000 | -8.8% | 5,651 | 0.0% | 0.26% | -2.6% |
| Q2 2022 | $329,453,000 | +62533.7% | 5,651 | -18.1% | 0.26% | -11.7% |
| Q1 2022 | $526,000 | -99.9% | 6,896 | +9.5% | 0.30% | +102.7% |
| Q4 2021 | $378,830,000 | +7.4% | 6,296 | 0.0% | 0.15% | +33.3% |
| Q3 2021 | $352,576,000 | -7.7% | 6,296 | 0.0% | 0.11% | 0.0% |
| Q2 2021 | $382,041,000 | -13.4% | 6,296 | 0.0% | 0.11% | -10.5% |
| Q1 2021 | $441,287,000 | +17.1% | 6,296 | 0.0% | 0.12% | +31.9% |
| Q4 2020 | $376,753,000 | – | 6,296 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |